Dx & Vx Co Ltd
KOSDAQ:180400
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Dx & Vx Co Ltd
EPS (Diluted)
Dx & Vx Co Ltd
EPS (Diluted) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
D
|
Dx & Vx Co Ltd
KOSDAQ:180400
|
EPS (Diluted)
-₩1k
|
CAGR 3-Years
-91%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
N/A
|
|
|
Celltrion Inc
KRX:068270
|
EPS (Diluted)
₩4.7k
|
CAGR 3-Years
9%
|
CAGR 5-Years
7%
|
CAGR 10-Years
17%
|
|
|
V
|
Voronoi Inc
KOSDAQ:310210
|
EPS (Diluted)
-₩1.9k
|
CAGR 3-Years
-14%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
|
|
Alteogen Inc
KOSDAQ:196170
|
EPS (Diluted)
₩2.6k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
55%
|
|
|
A
|
ABL Bio Inc
KOSDAQ:298380
|
EPS (Diluted)
-₩734
|
CAGR 3-Years
N/A
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
|
D
|
DND PharmaTech Inc
KOSDAQ:347850
|
EPS (Diluted)
-₩705
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Dx & Vx Co Ltd
Glance View
Dx & Vx Co., Ltd. engages in the development of molecular diagnostic products. The company is headquartered in Seoul, Seoul. The company went IPO on 2014-12-15. The Molecular Diagnosis Business segment is engaged in the manufacture and sale of deoxyribonucleic acid (DNA) chips, polymerase chain reaction (PCR) chips and other products. manufacture and sale of diagnostic reagents used for molecular diagnosis, and various enzymes and experimental reagents used for biological research.
See Also
What is Dx & Vx Co Ltd's EPS (Diluted)?
EPS (Diluted)
-1k
KRW
Based on the financial report for Sep 30, 2025, Dx & Vx Co Ltd's EPS (Diluted) amounts to -1k KRW.
What is Dx & Vx Co Ltd's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 5Y
-13%
Over the last year, the EPS (Diluted) growth was -7%. The average annual EPS (Diluted) growth rates for Dx & Vx Co Ltd have been -91% over the past three years , -13% over the past five years .
